Tara Moore Fails Doping Test, Handed 4-Year Ban—Follows Jannik Sinner in Doping Controversy Spotlight

Updated Jul 16, 2025 | 04:45 PM IST

SummaryJannik Sinner's name again came up for anti-doping tests and failing the same. Now, British tennis player, Tara Moore too is making news after she had failed her doping test which had been cleared 18 months ago. This has led to a 4-year-long ban. Which drugs were found in her tests? What impact does it have on the body. To know, continue to read.
After Jannik Sinner, Tara Moore Makes News Failing Her Doping Test, Resulting In A 4-Year Long Ban

Credits: Wikimedia Commons and Canva

After Jannik Sinner's news of anti-doping test, British tennis player Tara Moore is also making news. The 32-year-old was Britain's top ranked women's doubles player when she was provisionally banned in May 2022. Again, she has been banned for four years for a doping offence, though she had been cleared for the same by an independent tribunal just 18 months ago.

She was tested positive for nandrolone and boldenone at a tournament in the Colombian capital Bogota the previous month.

The reason Moore provided was due to the ingestion of contaminated meat. While in December 2023, an independent tribunal ruled that contaminated meat was the reason that the test came positive and Moore "bore no fault or negligence"; the International Tennis Integrity Agency (ITIA) thinks otherwise.

Also Read: Shubhanshu Shukla Returns From ISS, What All Medical Examinations Are Lined Up

ITIA has been upheld by the Court of Arbitration for Sport (Cas). In the March hearing, Cas said in a media release: "After reviewing the scientific and legal evidence, the majority of the Cas panel considered that the player did not succeed in proving that the concentration of nandrolone in her sample was consistent with the ingestion of contaminated meat."

This means Moore will not be free to play again until the start of 2028 season. "The panel concluded that Ms Moore failed to establish that the ADRV (Anti-Doping Rule Violation) was not intentional. The appeal by the ITIA is therefore upheld and the decision rendered by the Independent Tribunal is set aside."

The ITIA chief executive Karen Moorhouse told BBC,"For the ITIA, every case is considered according to the individual facts and circumstances. In this case, our independent scientific advice was that the player did not adequately explain the high level of nandrolone present in their sample. Today's ruling is consistent with this position."

What Do Nandrolone Decanoate And Boldenone Do To You?

Nandrolone Decanoate: As per a 2020 study published in journal Medicina, nandrolone decanoate is an androgen, which means it plays a significant role in the development of male reproductive organs. The study notes: "The clinical use of synthetic testosterone derivatives, such as nandrolone, is focused on maximizing the anabolic effects and minimizing the androgenic ones." The study also mentions that apart from its clinical use, skeletal muscles can be considered as the primary target tissue. "Nowadays, especially athletes in power sports such as bodybuilding and weightlifting administer illegally high doses of Anabolic Androgenic Steroids (AAS) to increase their muscle mass and improve their overall performance," notes the study.

Nandrolone Decanoate injections have been classified under the Anabolic Steroids Control Act of 1990 and due to its serious health risks, it is banned by most sports organization and is also listed in the prohibition list by the World Anti-Doping Agency (WADA).

Side Effects Include:

  • Infertility
  • Liver Toxicity
  • Impaired Lipid Profile
  • High Blood Pressure
  • Acne
  • Hair Loss
  • Gynecomastia

Boldenone: As per a 2016 study published in the Journal of Food and Drug Analysis, this AAS can be used in repairing wasting of the body caused by some emaciating disease. It can also be used for human sports for better performance and promoting the growth of skeletal muscle.

However, this is also used for increasing the body weight in livestock as growth-promoting agents. This is also one of the matters the study looks into, in order to "evaluate the safety and meat quality criteria in broilers following intramuscular injection of boldenone." This is the reason Moore too used in her defense, that the result of her positive test was contaminated meat.

The US Anti-Doping Agency (USADA) notes that there is no therapeutic or medical use for boldenone in humans. More specifically, it is not approved by the Food and Drug Administration (FDA) for use in humans for any reason. It also notes that WADA has included boldenone in its prohibited list. Since it could occur naturally at very low concentrations in the urine, WADA-accredited laboratories apply a specific analysis procedure called carbon isotope ratio mass spectrometry, or GC/C/IRMS, to differentiate between external administration and internal production.

What are the side effects? USADA notes that in men, boldenone causes decreased testosterone production and impacts the reproductive system and fertility of males. It also impacts the size of the testes, lower sperm count, and sperm mobility.

End of Article

Ozempic And Wegovy Prices Slashed Again In India To Counter Cheaper Generics

Updated Apr 1, 2026 | 04:00 PM IST

SummaryStarting today, the Ozempic price in India will be cut by 36 percent, while Wegovy has seen a steeper 48 percent reduction — limiting the base price below Rs 6,000 per month.
Ozempic And Wegovy Prices Slashed Again In India To Counter Cheaper Generics

Credit: iStock

Danish pharma giant Novo Nordisk has once again reduced the prices of its blockbuster drugs Ozempic and Wegovy in India. The strategic move is aimed at staying ahead of the entry of the low-cost generic competition in the country.

Starting today, the Ozempic price in India will be cut by 36 percent, while Wegovy has seen a steeper 48 percent reduction — limiting the base price below Rs 6,000 per month.

While Ozempic is available in three dose strengths of 0.25 mg, 0.5 mg, and 1 mg in India, Wegovy has five dose strengths.

Ozempic's and Wegovy's lowest doses of 0.25 ⁠mg will now be priced at Rs 1,415 for a weekly shot from Rs 2,200 and Rs 2,712 earlier, respectively, Novo Nordisk India said in a statement on Tuesday.

The average price reduction across doses is 23.8 percent for Ozempic and 27 percent for Wegovy, it added.

Speaking to the media, Novo Nordisk stated that the price cut will benefit a large section of people with diabetes and obesity in India.

The generic weight loss drugs will open up a huge customer base, especially in India, with a high burden of diabetes and obesity.

Novo first slashed Wegovy's price for the first time by up to 37 percent from its launch price last year.

In addition to the entry of generics, the launch of rival Eli Lilly's blockbuster diabetes and obesity drug Mounjaro in India in 2025.

Also read: Semaglutide Becomes Cheap In India: A Gamechanger Or Health Gamble?

Entry Of Generics In India

Soon after the end of Novo Nordisk's patent on semaglutide, on March 20, a host of companies in India launched generic versions of Ozempic.

This includes NATCO Pharma's Semanat and Semafull, priced at Rs 1,290 per month and Rs 1,750 — about 90 per cent cheaper than Ozempic, costing Rs 8,800 per month.

Eris Lifesciences also announced its plans to launch a multi-dose vial under the brand name Sundae at the same price.

Dr. Reddy’s Laboratories, Sun Pharmaceutical Industries, and Glenmark Pharmaceuticals have also launched their generic versions of semaglutide.

Dr. Reddy’s Obeda is priced at Rs 4,200 per month, available in 2 mg and 4 mg strengths.

Sun Pharmaceutical Industries will sell under the brand names Noveltreat (doses ranging from Rs 900) and Sematrinity (doses ranging from Rs 750). Meanwhile, Glenmark’s GLIPIQ vials range from Rs 325 to Rs 440 per week.

Zydus Lifesciences has also announced the launch of its generic version of semaglutide injection under the brand names SEMAGLYNTM, MASHEMATM, and ALTERMET. The average monthly cost of the treatment will be about Rs 2,200, the company said in a statement.

How Does Semaglutide Work?

Semaglutide works as a GLP-1 receptor agonist that mimics the GLP-1 hormone to regulate appetite and blood sugar. It slows gastric emptying and makes you feel fuller longer. It also signals the brain to reduce hunger and cravings, and triggers the pancreas to release insulin when blood sugar is high.

Also read: This Pill Is More Effective For Weight Loss Than Ozempic, Scientists Say

They work by increasing insulin release in a glucose-dependent manner, decreasing the liver's production of glucagon, and slowing down the emptying of the stomach, which helps lower blood sugar levels after a meal. They also act on the brain to suppress appetite and increase feelings of fullness, leading to reduced calorie intake.

In people with type 2 diabetes, notes Harvard Health, the body's cells are resistant to the effects of insulin and the body does not produce enough insulin, or both. This is when GLP-1 agonists stimulate the pancreas to release insulin and suppress the release of another hormone called glucagon.

These drugs also act in the brain to reduce hunger and act on the stomach to delay emptying, so you feel full for a longer time. These effects can lead to weight loss, which can be an important part of managing diabetes.

End of Article

Leptospirosis: US health officials flag outbreak risk after floods in Hawaii

Updated Apr 1, 2026 | 12:09 PM IST

SummaryThe Hawaii Department of Health (DOH) and the Hawaiian Humane Society (HHS) have urged residents and recovery workers to monitor for signs of leptospirosis that can affect both people and pets.
Leptospirosis: US health officials flag outbreak risk after floods in Hawaii

Credit: iStock

Health officials in the US have issued a risk of leptospirosis — a bacterial illness — in Hawaii, after the “Kona low” storm floods.

The Hawaii Department of Health (DOH) and the Hawaiian Humane Society (HHS) have urged residents and recovery workers to monitor for signs of leptospirosis that can affect both people and pets.

Leptospirosis is caused by bacteria Leptospira, which are carried in the urine of infected animals, including rats, mice, mongoose, livestock, and dogs.

The disease can spread via the urine of infected animals and can enter the human body through broken skin or through the mouth, nose, or eyes.

“Hawaii already has among the highest rates of leptospirosis in the country due to its warm, wet climate,” said HHS and DOH in a joint statement.

“Flooding events like the recent Kona low storm can dramatically increase exposure risk by spreading contaminated soil and water across a broad area,” it added.

The agency urged people to check out symptoms in pets, such as fever, decreased appetite, vomiting, diarrhea, and muscle soreness, and get medical help.

The risk of Leptospirosis outbreak is common after a storm, because the dead animals are likely to spread the bacteria. Further, flooding also forces rodents out of their burrows, leading them into homes, shelters, and debris piles where they shed bacteria more easily.

What Is Leptospirosis?

Leptospirosis is one of the most prevalent zoonotic diseases worldwide, often linked to poor sanitation and agricultural practices that involve contact with animals or contaminated water.

The bacteria can survive in contaminated water or soil for weeks to months, primarily spreading through the urine of infected animals.

Also read: With Rising Temperatures A Major Rat Infestation Is Taking Over The World- Why Is This A Health Hazard?

Humans can contract the disease through direct contact with infected urine or through contaminated food, water, or soil.

There are two main forms of leptospirosis: icteric leptospira, which presents with jaundice, and anicteric leptospira, a milder variant without jaundice. Leptospirosis can also manifest as Weil's disease, a severe complication.

What Are Symptoms Of Leptospirosis in humans?

Symptoms typically develop 2 to 30 days after exposure and can range from mild to severe. Initial signs often include

  • high-grade fever,
  • red eyes (conjunctival suffusion),
  • calf tenderness,
  • headache,
  • dry cough,
  • nausea,
  • diarrhea.
Also read: Nipah Virus: An 'Underestimated' Threat, Can Turn 'More Severe', Say Scientists

In more serious cases, the infection can lead to complications such as

  • jaundice,
  • kidney damage
  • liver damage,
  • meningitis,
  • respiratory issues,
  • hemorrhages.

Pulmonary hemorrhage — acute bleeding from the lungs — can also occur, posing life-threatening risks such as respiratory and renal failure. The illness may last from a few days to several weeks, and without treatment, recovery can take months, according to the US Centers for Disease Control and Prevention (CDC).

What Precautions Should Be Taken?

To reduce the risk of leptospirosis infection, individuals are advised to take several important precautions. According to the CDC, it is essential to avoid wading through dirty rainwater, especially during the rainy season, and to wear gumboots in such conditions.

Proper care of any injuries or cuts is crucial, and frequent handwashing, particularly after handling food or working in potentially contaminated environments, is highly recommended. Additionally, individuals should avoid contact with animals that appear sick or are known carriers of the bacteria.

Vaccination is also vital—pet owners should ensure their pets are vaccinated against leptospirosis, especially if they are frequently exposed to water or wildlife. Staying hydrated by drinking plenty of clean water and preventing water stagnation around the home can further minimize the risk of infection.

End of Article

Cicada COVID Variant: Use Masks To Avoid Transmission, Say Experts

Updated Apr 1, 2026 | 12:30 PM IST

SummaryExperts have urged people to follow COVID practices such as wearing masks in crowded areas or indoors where there is a high risk of transmission, and washing hands frequently.
Cicada COVID Variant: Use Masks To Avoid Transmission, Say Experts

Credit: Canva

The emerging COVID variant, BA 3.2, nicknamed “Cicada,” has revived memories of the COVID-19 pandemic that disrupted the world and raised fresh concerns about the possibility of severe illness.

The variant has been given the nickname “Cicada” due to its reappearance after remaining dormant or undetected for a long period, much like cicadas that emerge after years underground.

With the variant already spread to 23 nations, as of February, experts are urging people to use masks to avoid transmission.

What Is The Cicada COVID Variant?

Cicada was first identified in a respiratory sample in South Africa in November 2024.

It is a descendant of the Omicron BA.3 lineage, and is genetically distinct from the previously circulating JN.1 lineages (including LP.8.1 and XFG).

BA.3.2 comprises two major branches, BA.3.2.1 and BA.3.2.2. BA.3.2.2 also has substitutions like: K356T, A575S, R681H, and R1162P.

The World Health Organization (WHO) has designated BA.3.2 as a Variant Under Monitoring (VUM). It means the variant may not be that dangerous yet, but it may have concerning mutations.

As per the US CDC’s latest Morbidity and Mortality Weekly Report, Cicada has “70 to 75 substitutions and deletions in the gene sequence of its spike protein”.

Time To Mask Up

Dr. Sai Balasubramanian, a doctor and healthcare strategy executive, writing in Forbes, stressed the need to follow COVID practices such as masks and hand hygiene.

"Healthcare professionals recommend taking general precautions, similar to those used to prevent most viral transmission: get vaccinations when appropriate, wear masks in crowded areas or indoors where there is a high risk of transmission," he said.

He also urged “avoid individuals who have known illness or infections, wash hands frequently, and continue to stay apprised of local community guidelines and the infection spread”.

Cicada variant “is different from the (Covid-19) viruses we have been dealing with for the last two years," Prof Ravi Gupta, of Cambridge University, who advised the UK government during the pandemic, was quoted as saying by The Mirror.

Will The Cicada Variant Cause Severe Illness?

The SARS-CoV-2 virus has the potential to turn deadly in people, especially among vulnerable populations such as those with a weak immune system.

The Cicada variant is particularly concerning as it provides no immune protection to people with previous infection or even vaccination.

Yet, the World Health Organization and health experts advise that existing COVID vaccinations can help prevent severe illness and hospitalization.

"It would appear that all the protections we have from our experience with the virus and with vaccines probably offer more limited—not zero—but more limited protection against this strain," Dr. William Schaffner, professor of infectious diseases at Vanderbilt University Medical Center, was quoted as saying by Time.

Cicada Variant: Any New Symptoms?

The symptoms of Cicada aren't different from those of previous COVID variants. These include:

  • sore throat,
  • fever or chills,
  • headache,
  • cough,
  • body aches,
  • runny nose
  • nausea
  • diarrhea.

End of Article